Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 20 (7) , 836-848
Abstract
Atherosclerosis is a chronic, inflammatory disease characterized by a lipid-driven infiltration of inflammatory cells in large and medium arteries and is considered to be a major underlying cause of cardiovascular diseases. Cuproptosis, a novel form of cell death, is highly linked to mitochondrial metabolism and mediated by protein lipoylation. However, the clinical implication of cuproptosis-related genes (CRGs) in atherosclerosis remains unclear. In this study, genes collected from the GEO database intersected with CRGs were identified in atherosclerosis. GSEA, GO and KEGG pathway enrichment analyses were performed for functional annotation. Through the random forest algorithm and the construction of a protein-protein interaction (PPI) network, eight selected genes (LOXL2, SLC31A1, ATP7A, SLC31A2, COA6, UBE2D1, CP and SOD1) and a vital cuproptosis-related gene FDX1 were then further validated. Two independent datasets (GSE28829 (N = 29), GSE100927 (N = 104)) were collected to construct the signature of CRGs for validation in atherosclerosis. Consistently, the atherosclerosis plaques showed significantly higher expression of SLC31A1, SLC31A2 and lower expression of SOD1 than the normal intimae. The area under the curve (AUC) of SLC31A1, SLC31A2 and SOD1 performed well for the diagnostic validation in the two datasets. In conclusion, the cuproptosis-related gene signature could serve as a potential diagnostic biomarker for atherosclerosis and may offer novel insights into the treatment of cardiovascular diseases. Based on the hub genes, a competing endogenous RNA (ceRNA) network of lncRNA-miRNA-mRNA and a transcription factor regulation network were ultimately constructed to explore the possible regulatory mechanism in atherosclerosis.Keywords
This publication has 45 references indexed in Scilit:
- Mutations inCOA6cause CytochromecOxidase Deficiency and Neonatal Hypertrophic CardiomyopathyHuman Mutation, 2014
- Copper induces – and copper chelation by tetrathiomolybdate inhibits – endothelial activationin vitroRedox Report, 2013
- Ceruloplasmin and Heart Failure in the Atherosclerosis Risk in Communities StudyCirculation: Heart Failure, 2013
- The mammalian copper transporters CTR1 and CTR2 and their roles in development and diseaseThe International Journal of Biochemistry & Cell Biology, 2013
- Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation SequencingScience Translational Medicine, 2012
- Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Unexpected Role of the Copper Transporter ATP7A in PDGF-Induced Vascular Smooth Muscle Cell MigrationCirculation Research, 2010
- Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and CopperArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- CERULOPLASMIN METABOLISM AND FUNCTIONAnnual Review of Nutrition, 2002